Avalon GloboCare Corp. (ALBT)
NASDAQ: ALBT · Real-Time Price · USD
3.420
-0.470 (-12.08%)
At close: Dec 20, 2024, 4:00 PM
3.450
+0.030 (0.88%)
After-hours: Dec 20, 2024, 5:57 PM EST
Avalon GloboCare Revenue
Avalon GloboCare had revenue of $-102.75K in the quarter ending September 30, 2024, a decrease of -114.98%. This brings the company's revenue in the last twelve months to $-8.32M, down -622.43% year-over-year. In the year 2023, Avalon GloboCare had annual revenue of $-7.33M, down -732.09%.
Revenue (ttm)
$-8.32M
Revenue Growth
-622.43%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
3.74M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Wheeler Real Estate Investment Trust | 102.75M |
Ucommune International | 42.47M |
XChange TEC.INC | 10.63M |
Ohmyhome | 5.39M |
Power REIT | 3.15M |
New Concept Energy | 147.00K |
ALBT News
- 4 weeks ago - Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device - GlobeNewsWire
- 2 months ago - Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving - GlobeNewsWire
- 5 months ago - Avalon's Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction - GlobeNewsWire
- 7 months ago - Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report - GlobeNewsWire
- 8 months ago - Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference - GlobeNewsWire
- 9 months ago - Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union - GlobeNewsWire
- 1 year ago - Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US - GlobeNewsWire
- 1 year ago - Apple Approves Use of Avalon GloboCare's KetoAir Mobile Application - GlobeNewsWire